Additional lead improves defibrillation efficacy with an abdominal 'hot can' electrode system

Circulation

Volumn 96, Issue 12, 1997, Pages 4400-4407

  Yamanouchi, Yoshio ^a   Mowrey, Kent A ^a   Niebauer, Mark J ^a   Tchou, Patrick J ^a   Wilkoff, Bruce L ^a  

^a LERNER RESEARCH INSTITUTE   (United States)

Author keywords

Death, sudden; Defibrillation; Electrical stimulation; Ventricles

Indexed keywords

ABDOMEN; ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; AXILLA; CONTROLLED STUDY; DEFIBRILLATION; ELECTRODE; NONHUMAN; POSITION; PRIORITY JOURNAL; SUBCLAVIAN VEIN; SWINE; THORAX;

EID: 0031457129     PISSN: 00097322     EISSN: None     Source Type: Journal    
DOI: 10.1161/01.CIR.96.12.4400     Document Type: Article

References (40)

1. Mirowski M. The automatic implantable cardioverter-defibrillator: an overview. J Am Coll Cardiol. 1985;6:461-466.
2. Echt DS, Armstrong K, Schmidt P, Oyer PE, Stinson EB, Winkle RA. Clinical experience, complications, and survival in 70 patients with the automatic implantable cardioverter/defibrillator. Circulation. 1985;71:289-296.
3. Gabry MD, Brodman R, Johnston D, Frame R, Kim SG, Waspe LE, Fisher JD, Furman S. Automatic implantable cardioverterdefibrillator: patient survival, battery longevity and shock delivery analysis. J Am Coll Cardiol. 1987;9:1349-1356.
4. Kelly PA, Cannom DS, Garan H, Mirabal GS, Harthorne JW, Hurvitz RJ, Vlahakes GJ, Jacobs ML, Ilvento JP, Buckley MJ, Ruskin JN. The automatic implantable cardioverter-defibrillator: efficacy, complications and survival in patients with malignant ventricular arrhythmias. J Am Coll Cardiol. 1988;11:1278-1286.
5. Winkle RA, Mead RH, Ruder MA, Gaudiani VA, Smith NA, Buch WS, Schmidt P, Shipman T. Long-term outcome with the automatic implantable cardioverter-defibrillator. J Am Coll Cardiol. 1989;13: 1353-1361.
6. Fogoros RN, Elson JJ, Bonnet CA, Fiedler SB, Burkholder JA. Efficacy of the automatic implantable cardioverter-defibrillator in prolonging survival in patients with severe underlying cardiac disease. J Am Coll Cardiol. 1990;16:381-386.
7. Tchou PJ, Kadri N, Anderson J, Caceres JA, Jazayeri M, Akhtar M. Automatic implantable cardioverter defibrillators and survival of patients with left ventricular dysfunction and malignant ventricular arrhythmias. Ann Intern Med. 1988;109:529-534.
8. Bardy GH, Allen MD, Mehra R, Johnson G. An effective and adaptable transvenous defibrillation system using the coronary sinus in humans. J Am Coll Cardiol. 1990;16:887-895.
9. McCowan R, Maloney J, Wilkoff B, Simmons T, Khoury D, McAlister H, Morant V, Castle L. Automatic implantable cardioverter-defibrillator implantation without thoracotomy using an endocardial and submuscular patch system. J Am Coll Cardiol. 1991;17:415-421.
10. Yee R, Klein GJ, Leitch JW, Guiraudon GM, Guiraudon CM, Jones DL, Norris C. A permanent transvenous lead system for an implantable pacemaker cardioverter-defibrillator: nonthoracotomy approach to implantation. Circulation. 1992;85:196-204.
11. Neuzner J. Clinical experience with a new cardioverter defibrillator capable of biphasic waveform pulse and enhanced data storage: results of prospective multicenter study. Pacing Clin Electrophysiol. 1994;17:1243-1255.
12. Sweeney M, Ruskin JN. Mortality benefits and the implantable cardioverter-defibrillator. Circulation. 1994;89:1851-1858.
13. Bardy GH, Johnson G, Poole JE, Dolack GL, Kudenchuk PJ, Kelso D, Mitchell R, Mehra R, Hofer B. A simplified, single-lead unipolar transvenous cardioversion-defibrillation system. Circulation. 1993; 88:543-547.
14. Raitt MH, Johnson G, Dolack GL, Poole JE, Kudenchuk PJ, Bardy GH. Clinical predictors of the defibrillation threshold with the unipolar implantable defibrillation system. J Am Coll Cardiol. 1995; 25:1576-1583.
15. Bardy GH, Yee R, Jung W. Multicenter experience with a pectoral unipolar implantable cardioverter-defibrillator. J Am Coll Cardiol. 1996;28:400-410.
16. Gold MR, Shorofsky SR. Transvenous defibrillation lead systems. J Cardiovasc Electrophysiol. 1996;7:570-580.
17. Schofield IJ, Bennett DH. Right sided pectoral implantation of an 'active can' transvenous implantable cardioverter-defibrillator with single right ventricular lead. Br Heart J. 1995;74:204.
18. Seidl K, Hauer B, Schwick N, Werling C, Isgro F, Senges J. Is the pectoral implantation site of the 'active can' cardioverter/ defibrillator device of importance for the defibrillation threshold? J Am Coll Cardiol. 1996;27:348A. Abstract.
19. Min X, Mehra R. Finite element analysis of effect of can electrode position for Can-RV. Pacing Clin Electrophysiol. 1996;19:655. Abstract.
20. Brewer JE, Tvedt MA, Adams TP, Kroll MW. Low voltage shocks have a significantly higher tilt of the internal electric field than do high voltage shocks. Pacing Clin Electrophysiol. 1995;18:214-220.
21. Rist K, Tchou PJ, Mowrey KA, Kroll MW, Brewer JE. Smaller capacitors improve the biphasic waveform. J Cardiovasc Electrophysiol. 1994;5:771-776.
22. Yamanouchi Y, Mowrey KA, Nadzam GR, Hills DO, Kroll MW, Brewer JE, Donohoo AM, Wilkoff BL, Tchou PJ. Large change in voltage at phase reversal improves biphasie defibrillation thresholds: parallel-series mode switching. Circulation. 1996;94: 1768-1773.
23. Kirk RE. A priori nonorthogonal contrasts. In: Kirk RE ed. Experimental Design: Procedures for the Behavioral Sciences. Belmont, Calif: Brooks/Cole Publishing Co; 1982:106-110.
24. Chang MS, Inoue H, Kallok MJ, Zipes DP. Double and triple sequential shocks reduce ventricular defibrillation threshold in dogs with and without myocardial infarction. J Am Coll Cardiol. 1986;8: 1393-1405.
25. Ideker RE, Wolf PD, Alferness C, Krassowska W, Smith WM. Current concepts for selecting the location, size and shape of defibrillation electrodes. Pacing Clin Electrophysiol. 1991;14:227-240.
26. Oeff M, Abbott JA, Scheinman ED, Yee ES, Scheinman MM, Griffin JC. Determination of patch electrode position for the internal cardioverter-defibrillator by cine computed tomography and its relation to the defibrillation threshold. J Am Coll Cardiol. 1992;20:210-217.
27. Kenknight BH, Heil JE, Hahn SJ, Lang DJ. Position of epicardial patch electrodes for implantable defibrillation significantly affects shock strength requirements. Acad Emerg Med. 1995;2:50-56.
28. Stajduhar KC, Ott GY, Kron J, McAnulty JH, Oliver RP, Reynolds BT, Adler SW, Halperin BD. Optimal electrode position for transvenous defibrillation: a prospective randomized study. J Am Coll Cardiol. 1996;27:90-94.
29. Saksena S, DeGroot P, Krol RB, Raju R, Mathew P, Mehra R. Low-energy endocardial defibrillation using an axillary or a pectoral thoracic electrode location. Circulation. 1993;88:2655-2660.
30. Bardy GH, Dolack GL, Kudenchuk PJ, Poole JE, Mehra R, Johnson G. Prospective, randomized comparison in humans of a unipolar defibrillation system with that using an additional superior vena cava electrode. Circulation. 1994;89:1090-1093.
31. Kudenchuk PJ, Bardy GH, Dolack GL, Poole JE, Mehra R, Johnson G. Efficacy of a single-lead unipolar transvenous defibrillator compared with a system employing an additional coronary sinus electrode: a prospective, randomized study. Circulation. 1994; 89:2641-2644.
32. Jung W, Frazier DW, Saksena S, Stanton MS, Thakur RK, DeGroot PJ. Paired randomized comparison of defibrillation threshold with Can-RV and Can+SVC-RV lead systems. Circulation. 1996;94(suppl I):I-438. Abstract.
33. Min X, DeGroot PJ, Mehra R. Finite element analysis of Can+SVC and Can-RV electrode system for ventricular defibrillation and comparisons with the clinical data. Circulation. 1996; 94(suppl I):I-439. Abstract.
34. Kerber RE, Kouba C, Martins J, Kelly K, Low R, Hoyt R, Ferguson D, Bailey L, Bennett P, Charbonnier F. Advance prediction of transthoracic impedance in human defibrillation and cardioversion: importance of impedance in determining the success of low-energy shocks. Circulation. 1984;70:303-308.
35. Chen PS, Wolf PD, Claydon FJ, Dixon EG, Vidaillet HJ Jr, Danieley ND, Pilkington TC, Ideker RE. The potential gradient field created by epicardial defibrillation electrodes in dogs. Circulation. 1986;74:626-636.
36. Lerman BB, Halperin HR, Tsitlik JE, Brin K, Clark CW, Deale OC. Relationship between canine transthoracic impedance and defibrillation threshold: evidence for current-based defibrillation. J Clin Invest. 1987;80:797-803.
37. Kerber RE, Martins JB, Kienzle MG, Constantin L, Olshansky B, Hopson R, Charbonnier F. Energy, current, and success in defibrillation and cardioversion: clinical studies using an automated impedance-based method of energy adjustment. Circulation. 1988; 77:1038-1046.
38. Wharton JM, Wolf PD, Smith WM, Chen PS, Frazier DW, Yabe S, Danieley N, Ideker RE. Cardiac potential and potential gradient fields generated by single, combined, and sequential shocks during ventricular defibrillation. Circulation. 1992;85:1510-1523.
39. Zhou X, Daubert JP, Wolf PD, Smith WM, Ideker RE. Epicardial mapping of ventricular defibrillation with monophasic and biphasic shocks in dogs. Circ Res. 1993;72:145-160.
40. Tullo NG, Saksena S, Krol RB, Mauro AM, Kunecz D. Management of complications associated with a first-generation endocardial defibrillation lead system for implantable cardioverterdefibrillators. Am J Cardiol. 1990;66:411-415.